CR, T., E, B., W, K., L, M., P, H., A, V., . . . JD, S. (2019). Cost-effectiveness of early cancer surveillance for patients with Li-Fraumeni syndrome. Pediatric blood & cancer, 66(5), e27629. https://doi.org/10.1002/pbc.27629
Chicago Style (17th ed.) CitationCR, Tak, et al. "Cost-effectiveness of Early Cancer Surveillance for Patients with Li-Fraumeni Syndrome." Pediatric Blood & Cancer 66, no. 5 (2019): e27629. https://doi.org/10.1002/pbc.27629.
MLA (9th ed.) CitationCR, Tak, et al. "Cost-effectiveness of Early Cancer Surveillance for Patients with Li-Fraumeni Syndrome." Pediatric Blood & Cancer, vol. 66, no. 5, 2019, p. e27629, https://doi.org/10.1002/pbc.27629.
Warning: These citations may not always be 100% accurate.